Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FD6G7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on July 24, 2025, with completion scheduled for August 14, 2025. This firm fixed price, competitively awarded contract (no set-aside used) will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
Vyndamax is a brand-name pharmaceutical used in the treatment of cardiac amyloidosis, representing a specialized medical commodity within the broader portfolio of pharmaceutical products AmerisourceBergen supplies to federal healthcare systems. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerisourceBergen leverages its position as a prime vendor to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. This award reflects AmerisourceBergen's demonstrated capability to meet federal medical procurement requirements and its role in supporting the Defense Logistics Agency's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DB25FD6G7?
SPE2DB25FD6G7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FD6G7 worth?
The government has obligated $13,847 on SPE2DB25FD6G7.
Is contract SPE2DB25FD6G7 an order under another contract?
Yes. SPE2DB25FD6G7 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FD6G7 competed?
The extent of competition for SPE2DB25FD6G7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award